Patent · US Active

Use of transcranial magnetic stimulation to modulate permeability of the blood-brain barrier

US11241584B2 · kind B2 · utility

3Cited by

0References

35Claims

0Family size

Assignee

BRAINSWAY LTD. · IL

Inventors

Gaby Pell · Jerusalem, IL
Abraham Zangen · Jerusalem, IL
Yiftach Roth · Nehalim, IL
Alon Friedman · Ramat HaSharon, IL
Udi Vazana · Ashdod, IL

Key dates

Filing date	Jul 2, 2019
Grant date	Feb 8, 2022
Priority date	—
Expiry date	Jan 22, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61N2/02
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

Transcranial magnetic stimulation (TMS) is used to modulate permeability of the blood brain barrier in a transient, safe and non-invasive manner. A conventional or deep TMS coil may be placed on a head in a vicinity of a tumor, for example. A series of magnetic pulses is provided to the brain with a tailored stimulation protocol. In one of many possible clinical applications, a pharmaceutical substance may be introduced during a time frame before, during or after providing the magnetic pulses to treat a tumor in the brain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.